David J. McConkey, Ph.D., is the inaugural director of the Johns Hopkins Greenberg Bladder Cancer Institute, Professor in the Department of Urology at Johns Hopkins Medicine, and The Erwin and Stephanie Greenberg Professor of Urology at the James Buchanan Brady Urological Institute. He received his undergraduate degree from Brown University and completed his doctoral thesis work at the Karolinska Institute, Stockholm, Sweden. He performed his postdoctoral research at the Dana-Farber Cancer Institute, Harvard Medical School before joining the faculty at University of Texas M.D. Anderson Cancer Center, where he served as Director of Urological Research from 2008-16. He is co-Principal Investigator of the M.D. Anderson Specialized Program of Research Excellence (SPORE) in Bladder Cancer, which is now in its third continuous cycle of funding from the National Cancer Institute (NCI). He is also Chair for Translational Medicine for the Genitourinary Cancers Committee in the Southwest Oncology Group (SWOG).

Research in Dr. McConkey’s laboratory is focused on using genomics to define the molecular mechanisms involved in bladder cancer progression and developing novel therapies for muscle-invasive and metastatic disease. His mission is to make the Johns Hopkins Greenberg Bladder Cancer Institute a hub of an institutional and international community of researchers who share a commitment to advancing the scientific understanding of bladder cancer and improving its treatment.